Balloon catheter is a flexible device with a balloon at its tip, which may be inflated or deflated when the catheter is in place to create or enlarge a passageway, also it is used to remove the blockage or to open the narrowed coronary arteries caused by coronary arteries disease. Furthermore, the balloon catheters have other applications such as are used in renal denervation, cryoablation, drug delivery, perfusion, and atherectomy.
Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/489
As per the stats published in 2015 by The Heart Foundation, coronary artery disease causes around 380,000 fatalities yearly in the U.S. Furthermore, around 720,000 people suffer from heart attacks each year and among these, 205,000 are repetitive cases of a heart attack and 515,000 people suffers from a first incidence of heart attack in the U.S.
The global balloon catheters market was valued at US$ 2833.4 million in 2016 and is expected to witness a robust CAGR of 7.7% during the forecast period (2017 – 2025).
Rising incidence of cardiovascular disease and coronary heart disease cases due to increase in the prevalence of diabetes, high blood pressure cases and number of smokers worldwide is expected to favor the demand for balloon catheters around the globe.
According to World Health Organization (WHO), in 2015 around 17.7 million people died due to cardiovascular disease worldwide, and out of this total deaths around 7.4 million were die due to coronary heart disease. Furthermore, the majority of deaths are occurred in emerging economies due to high prevalence rate and lack of healthcare services in rural areas.
Also, increasing aging population and rising demand for minimally invasive procedures are the other factors leading to the growth of balloon catheters market in developed as well as emerging economies.
As per United Nations Population Fund, people aged 60 years and above accounted for 12.3% of the global population in 2015, which is expected to increase to 22% by 2050. The factors behind aging population in developed region are developed healthcare services and access of healthcare facilities to people, better nutrition, sanitation and economic development.
This report segments the global balloon catheters market on the basis of product material and geography. On the basis of material, the market is categorized into polyurethane, nylon and other type of materials such as pebax. Among these, the polyurethane segment dominate the balloon catheters market throughout the forecast period. On the basis of geography, the market is divided into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Among all regions, North America contributes major market share supported by increased incidence rate of cardiovascular disease and growing inclination of the populace towards minimally invasive procedures.
Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/market-insight/balloon-catheters-market-489
High cases of coronary artery disease and heart surgery procedures is expected to fuel the growth of balloon catheters market
Factors such as high incidence of coronary artery diseases with increasing heart surgery procedures will propel growth in balloon catheters market. For instance, according to National Health Service (NHS), around 20,000 coronary artery bypass surgery is performed annually in England. According to Coronary Artery Disease among Asian Indians (CADI) Research Foundation, around 60,000 coronary artery bypass surgery performed every year in India. The same source highlights that the number of coronary artery bypass surgery will keep on rising due to increasing geriatric population with diabetes cases and high blood cholesterol level.
The key players operating in balloon catheters market are Abbott Laboratories, Becton Dickinson And Company, Boston Scientific Corporation, Bard Medical Division, B. Braun Melsungen AG, Johnson & Johnson, Teleflex Incorporated, Medtronic, Plc, Edwards Lifesciences Corporation, OrbusNeich and Vascular Solutions, Inc.